The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Insertable Heart Monitors Market Research Report 2024
Synopsis
Implantable cardiac monitors (ICM) are small electrophysiology (EP) devices that used for long-term monitoring of a patient's heart electrical activity to detect arrhythmias. The technology can eliminate the need for a bulkly external Holter monitor that requires wire leads attached to the patient. ICMs can be inserted under the skin during and office visit and record cardiac data continuously for up to 4.5 years.
Global Insertable Heart Monitors market is projected to reach US$ 997.1 million in 2029, increasing from US$ 502 million in 2022, with the CAGR of 7.2% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Insertable Heart Monitors market research.
Abnormal heartbeats are called arrhythmias. It causes a decrease in the heart's ability to pump blood, which reduces blood supply to vital organs such as the brain. Without proper blood flow to the brain, it can cause a person to faint, and when the rhythm returns to normal, the person regains consciousness. Therefore, heart rhythm is associated with many diseases and requires treatment. It is important to look for the cause of the rhythm disturbance and monitor electrical activity. This can be monitored with the help of an implantable heart monitor, which has a battery life of up to three or four years. The ICM continuously monitors heart rhythm and automatically stores records for years in real-world scenarios. With the capability of long-term continuous monitoring, ICM has proven to be a sensitive method for detecting unexplained syncope, subclinical atrial fibrillation and palpitations. These devices automatically record heart rate without any external intervention. The ICM can capture information that is often missed by a Holter or standard electrocardiogram (ECG), but some heart rhythm abnormalities occur rarely. Existing studies of these devices have provided sufficient evidence that implantable heart monitors are suitable for patients with atrial fibrillation, syncope and even myocardial infarction.
Atrial fibrillation is an irregular and often rapid heart rate that increases the risk of stroke, heart failure and other heart-related complications. It is expected to affect 17.9 million people by 2050. Short-term monitoring is not optimal for understanding the burden. After radiofrequency ablation, the ICM has become the first choice for cardiac monitoring. Fainting is a disorder triggered by a sudden, temporary drop in blood flow to the brain, resulting in loss of consciousness and muscle control. This is due to decreased blood flow to the brain or any other organ in the body. Low blood pressure can also cause passing out. The International Study of Syncope of Unknown Etiology (ISSUE) highlights various aspects of the utility of ICMs in the transient loss of consciousness (TLOC) population. It has been observed that ICM is used more in syncope than conventional testing. Myocardial infarction, commonly known as a heart attack, is said to occur when blood flow to the heart is blocked or completely stopped. The use of ICMs in patients with acute myocardial infarction allows for continuous ECG monitoring and a more detailed understanding of the incidence of bradyarrhythmias and tachyarrhythmias than conventional follow-up.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Insertable Heart Monitors market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Medtronic
Abbott
Boston Scientific Corporation
BIOTRONIK
Vectorious
LivaNova
Phoenix Heart
Angel Medical Systems
Segment by Type
Implantation Loop Recorder (ILR)
Insertable Cardiac Monitor (ICM)
Segment by Application
Medical
Household
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Insertable Heart Monitors report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Implantable cardiac monitors (ICM) are small electrophysiology (EP) devices that used for long-term monitoring of a patient's heart electrical activity to detect arrhythmias. The technology can eliminate the need for a bulkly external Holter monitor that requires wire leads attached to the patient. ICMs can be inserted under the skin during and office visit and record cardiac data continuously for up to 4.5 years.
Global Insertable Heart Monitors market is projected to reach US$ 997.1 million in 2029, increasing from US$ 502 million in 2022, with the CAGR of 7.2% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Insertable Heart Monitors market research.
Abnormal heartbeats are called arrhythmias. It causes a decrease in the heart's ability to pump blood, which reduces blood supply to vital organs such as the brain. Without proper blood flow to the brain, it can cause a person to faint, and when the rhythm returns to normal, the person regains consciousness. Therefore, heart rhythm is associated with many diseases and requires treatment. It is important to look for the cause of the rhythm disturbance and monitor electrical activity. This can be monitored with the help of an implantable heart monitor, which has a battery life of up to three or four years. The ICM continuously monitors heart rhythm and automatically stores records for years in real-world scenarios. With the capability of long-term continuous monitoring, ICM has proven to be a sensitive method for detecting unexplained syncope, subclinical atrial fibrillation and palpitations. These devices automatically record heart rate without any external intervention. The ICM can capture information that is often missed by a Holter or standard electrocardiogram (ECG), but some heart rhythm abnormalities occur rarely. Existing studies of these devices have provided sufficient evidence that implantable heart monitors are suitable for patients with atrial fibrillation, syncope and even myocardial infarction.
Atrial fibrillation is an irregular and often rapid heart rate that increases the risk of stroke, heart failure and other heart-related complications. It is expected to affect 17.9 million people by 2050. Short-term monitoring is not optimal for understanding the burden. After radiofrequency ablation, the ICM has become the first choice for cardiac monitoring. Fainting is a disorder triggered by a sudden, temporary drop in blood flow to the brain, resulting in loss of consciousness and muscle control. This is due to decreased blood flow to the brain or any other organ in the body. Low blood pressure can also cause passing out. The International Study of Syncope of Unknown Etiology (ISSUE) highlights various aspects of the utility of ICMs in the transient loss of consciousness (TLOC) population. It has been observed that ICM is used more in syncope than conventional testing. Myocardial infarction, commonly known as a heart attack, is said to occur when blood flow to the heart is blocked or completely stopped. The use of ICMs in patients with acute myocardial infarction allows for continuous ECG monitoring and a more detailed understanding of the incidence of bradyarrhythmias and tachyarrhythmias than conventional follow-up.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Insertable Heart Monitors market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Medtronic
Abbott
Boston Scientific Corporation
BIOTRONIK
Vectorious
LivaNova
Phoenix Heart
Angel Medical Systems
Segment by Type
Implantation Loop Recorder (ILR)
Insertable Cardiac Monitor (ICM)
Segment by Application
Medical
Household
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Insertable Heart Monitors report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 Insertable Heart Monitors Market Overview
1.1 Product Overview and Scope of Insertable Heart Monitors
1.2 Insertable Heart Monitors Segment by Type
1.2.1 Global Insertable Heart Monitors Market Value Comparison by Type (2023-2029)
1.2.2 Implantation Loop Recorder (ILR)
1.2.3 Insertable Cardiac Monitor (ICM)
1.3 Insertable Heart Monitors Segment by Application
1.3.1 Global Insertable Heart Monitors Market Value by Application: (2023-2029)
1.3.2 Medical
1.3.3 Household
1.4 Global Insertable Heart Monitors Market Size Estimates and Forecasts
1.4.1 Global Insertable Heart Monitors Revenue 2018-2029
1.4.2 Global Insertable Heart Monitors Sales 2018-2029
1.4.3 Global Insertable Heart Monitors Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Insertable Heart Monitors Market Competition by Manufacturers
2.1 Global Insertable Heart Monitors Sales Market Share by Manufacturers (2018-2023)
2.2 Global Insertable Heart Monitors Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Insertable Heart Monitors Average Price by Manufacturers (2018-2023)
2.4 Global Insertable Heart Monitors Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Insertable Heart Monitors, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Insertable Heart Monitors, Product Type & Application
2.7 Insertable Heart Monitors Market Competitive Situation and Trends
2.7.1 Insertable Heart Monitors Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Insertable Heart Monitors Players Market Share by Revenue
2.7.3 Global Insertable Heart Monitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Insertable Heart Monitors Retrospective Market Scenario by Region
3.1 Global Insertable Heart Monitors Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Insertable Heart Monitors Global Insertable Heart Monitors Sales by Region: 2018-2029
3.2.1 Global Insertable Heart Monitors Sales by Region: 2018-2023
3.2.2 Global Insertable Heart Monitors Sales by Region: 2024-2029
3.3 Global Insertable Heart Monitors Global Insertable Heart Monitors Revenue by Region: 2018-2029
3.3.1 Global Insertable Heart Monitors Revenue by Region: 2018-2023
3.3.2 Global Insertable Heart Monitors Revenue by Region: 2024-2029
3.4 North America Insertable Heart Monitors Market Facts & Figures by Country
3.4.1 North America Insertable Heart Monitors Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Insertable Heart Monitors Sales by Country (2018-2029)
3.4.3 North America Insertable Heart Monitors Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Insertable Heart Monitors Market Facts & Figures by Country
3.5.1 Europe Insertable Heart Monitors Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Insertable Heart Monitors Sales by Country (2018-2029)
3.5.3 Europe Insertable Heart Monitors Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Insertable Heart Monitors Market Facts & Figures by Country
3.6.1 Asia Pacific Insertable Heart Monitors Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Insertable Heart Monitors Sales by Country (2018-2029)
3.6.3 Asia Pacific Insertable Heart Monitors Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Insertable Heart Monitors Market Facts & Figures by Country
3.7.1 Latin America Insertable Heart Monitors Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Insertable Heart Monitors Sales by Country (2018-2029)
3.7.3 Latin America Insertable Heart Monitors Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Insertable Heart Monitors Market Facts & Figures by Country
3.8.1 Middle East and Africa Insertable Heart Monitors Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Insertable Heart Monitors Sales by Country (2018-2029)
3.8.3 Middle East and Africa Insertable Heart Monitors Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Insertable Heart Monitors Sales by Type (2018-2029)
4.1.1 Global Insertable Heart Monitors Sales by Type (2018-2023)
4.1.2 Global Insertable Heart Monitors Sales by Type (2024-2029)
4.1.3 Global Insertable Heart Monitors Sales Market Share by Type (2018-2029)
4.2 Global Insertable Heart Monitors Revenue by Type (2018-2029)
4.2.1 Global Insertable Heart Monitors Revenue by Type (2018-2023)
4.2.2 Global Insertable Heart Monitors Revenue by Type (2024-2029)
4.2.3 Global Insertable Heart Monitors Revenue Market Share by Type (2018-2029)
4.3 Global Insertable Heart Monitors Price by Type (2018-2029)
5 Segment by Application
5.1 Global Insertable Heart Monitors Sales by Application (2018-2029)
5.1.1 Global Insertable Heart Monitors Sales by Application (2018-2023)
5.1.2 Global Insertable Heart Monitors Sales by Application (2024-2029)
5.1.3 Global Insertable Heart Monitors Sales Market Share by Application (2018-2029)
5.2 Global Insertable Heart Monitors Revenue by Application (2018-2029)
5.2.1 Global Insertable Heart Monitors Revenue by Application (2018-2023)
5.2.2 Global Insertable Heart Monitors Revenue by Application (2024-2029)
5.2.3 Global Insertable Heart Monitors Revenue Market Share by Application (2018-2029)
5.3 Global Insertable Heart Monitors Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Medtronic
6.1.1 Medtronic Corporation Information
6.1.2 Medtronic Description and Business Overview
6.1.3 Medtronic Insertable Heart Monitors Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Medtronic Insertable Heart Monitors Product Portfolio
6.1.5 Medtronic Recent Developments/Updates
6.2 Abbott
6.2.1 Abbott Corporation Information
6.2.2 Abbott Description and Business Overview
6.2.3 Abbott Insertable Heart Monitors Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Abbott Insertable Heart Monitors Product Portfolio
6.2.5 Abbott Recent Developments/Updates
6.3 Boston Scientific Corporation
6.3.1 Boston Scientific Corporation Corporation Information
6.3.2 Boston Scientific Corporation Description and Business Overview
6.3.3 Boston Scientific Corporation Insertable Heart Monitors Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Boston Scientific Corporation Insertable Heart Monitors Product Portfolio
6.3.5 Boston Scientific Corporation Recent Developments/Updates
6.4 BIOTRONIK
6.4.1 BIOTRONIK Corporation Information
6.4.2 BIOTRONIK Description and Business Overview
6.4.3 BIOTRONIK Insertable Heart Monitors Sales, Revenue and Gross Margin (2018-2023)
6.4.4 BIOTRONIK Insertable Heart Monitors Product Portfolio
6.4.5 BIOTRONIK Recent Developments/Updates
6.5 Vectorious
6.5.1 Vectorious Corporation Information
6.5.2 Vectorious Description and Business Overview
6.5.3 Vectorious Insertable Heart Monitors Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Vectorious Insertable Heart Monitors Product Portfolio
6.5.5 Vectorious Recent Developments/Updates
6.6 LivaNova
6.6.1 LivaNova Corporation Information
6.6.2 LivaNova Description and Business Overview
6.6.3 LivaNova Insertable Heart Monitors Sales, Revenue and Gross Margin (2018-2023)
6.6.4 LivaNova Insertable Heart Monitors Product Portfolio
6.6.5 LivaNova Recent Developments/Updates
6.7 Phoenix Heart
6.6.1 Phoenix Heart Corporation Information
6.6.2 Phoenix Heart Description and Business Overview
6.6.3 Phoenix Heart Insertable Heart Monitors Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Phoenix Heart Insertable Heart Monitors Product Portfolio
6.7.5 Phoenix Heart Recent Developments/Updates
6.8 Angel Medical Systems
6.8.1 Angel Medical Systems Corporation Information
6.8.2 Angel Medical Systems Description and Business Overview
6.8.3 Angel Medical Systems Insertable Heart Monitors Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Angel Medical Systems Insertable Heart Monitors Product Portfolio
6.8.5 Angel Medical Systems Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Insertable Heart Monitors Industry Chain Analysis
7.2 Insertable Heart Monitors Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Insertable Heart Monitors Production Mode & Process
7.4 Insertable Heart Monitors Sales and Marketing
7.4.1 Insertable Heart Monitors Sales Channels
7.4.2 Insertable Heart Monitors Distributors
7.5 Insertable Heart Monitors Customers
8 Insertable Heart Monitors Market Dynamics
8.1 Insertable Heart Monitors Industry Trends
8.2 Insertable Heart Monitors Market Drivers
8.3 Insertable Heart Monitors Market Challenges
8.4 Insertable Heart Monitors Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
